4/A: Twist Bioscience Chief Accounting Officer Sells Shares to Cover Tax Obligations

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 1,448 shares of common stock to cover tax obligations related to vesting Performance Stock Units.

Summary

• Robert F. Werner, Chief Accounting Officer of Twist Bioscience, sold 1,448 shares of common stock on November 6, 2024.
• The sale was executed at a price of $44.605 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of Performance Stock Units (PSUs).
• The sale was not a discretionary trade by the reporting person but was mandated by the issuer's equity incentive plans.
• Following the transaction, Werner directly owns 45,620 shares of Twist Bioscience stock.
• This is an amendment to a previous filing on November 8, 2024, solely to correct footnote 1.

Sentiment

Score: 5

Explanation: The document reports a routine transaction related to tax obligations, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It does not indicate any change in the company's performance or outlook.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold and the price are not unusual for a company of Twist Bioscience's size and stage.
• Similar transactions are regularly reported by executives at comparable biotech companies such as Ginkgo Bioworks and Amyris.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• The sale does not affect the company's operations or financial health.

Key Dates

Keywords

Twist Bioscience, Robert F. Werner, Chief Accounting Officer, stock sale, tax obligations, Performance Stock Units, PSUs, equity incentive plans, Form 4, insider trading